Patent ID: RE44578

Claim:
A stabilized method of stabilizing an active component in a pharmaceutical composition for the treatment of dyslipidemia, comprising combining: an active component consisting essentially of one or more compounds selected from the group consisting of (i) a n HMG-CoA reductase inhibiting ring-opened 7 -substituted- 3 , 5 -dihydroxyheptafloic 7-substituted-3,5-dihydroxyhepatonic acid or a pharmaceutically acceptable acid salt thereof, and (ii) a n HMG-CoA reductase inhibiting ring-opened 7 -substituted- 3 , 5 -dihydroxyheptenoic acid or a pharmaceutically acceptable acid salt thereof, and a stabilizing effective amount of at least one amido-group tertiary amide group containing polymeric compound or at least one amino-group containing polymeric compound, or combination thereof, to form a stabilized pharmaceutical composition, wherein said stabilized pharmaceutical composition does not contain a stabilizing effective amount of another stabilizer or a combination of other stabilizers.